战争中阻止脊髓灰质炎暴发:叙利亚的经验教训
本文描述了2017年叙利亚战争期间发生的2型循环疫苗衍生脊髓灰质炎病毒(cVDPV2)暴发,分析了基于疫苗接种的风险因素及应对措施。共报告74例cVDPV2病例,其中84%接受口服脊髓灰质炎疫苗(OPV)少于3剂;暴发地区6-59月龄非脊灰急性弛缓性麻痹(AFP)病例未接种OPV的比值比为2.5(95%CI:1.1-5.7)。开展三轮单价OPV2(mOPV2)疫苗接种后,省级覆盖率大多超过80%,疫情得到成功控制。
要点
- 战争导致国家和地方脊灰疫苗接种覆盖率显著下降,引发cVDPV2暴发。
- 暴发地区6-59月龄儿童未接种OPV的比值比为2.5(95%CI:1.1-5.7)。
- 三轮mOPV2疫苗接种(省级覆盖率多超80%)成功控制了疫情。
核心结论
- 战争和人道主义危机导致脊灰疫苗接种覆盖率下降,引发cVDPV2暴发,但三轮mOPV2疫苗接种成功控制疫情。
研究设计与样本
- 对2016-2018年cVDPV2病例及脊灰病毒监测和疫苗接种活动关键指标进行描述性分析。
- 使用非脊灰AFP病例看护人报告的疫苗接种状态作为疫苗接种覆盖率的替代指标。
- 比较暴发地区与其他地区儿童未接种脊灰疫苗的相对比值比,以评估免疫缺口。
主要发现
- 共报告74例cVDPV2病例,瘫痪发病日期为2017年3月3日至9月21日。
- 除3例以外,所有病例均报告自代尔祖尔省,84%的病例接受OPV少于3剂。
- 调整年龄和性别后,暴发地区6-59月龄非脊灰AFP病例未接种OPV的比值比为2.5(95%CI:1.1-5.7),高于叙利亚其他地区同年龄组。
- 开展三轮mOPV2疫苗接种,省级覆盖率大多超过80%。
关键数值与推荐
- 病例定义:cVDPV2病例,瘫痪发病日期在2017年3月3日至9月21日。
- 疫苗接种覆盖率替代指标:非脊灰AFP病例看护人报告的疫苗接种状态。
- 暴发应对:三轮mOPV2疫苗接种,省级覆盖率大多超过80%。
临床怎么用
- 在冲突地区应维持脊灰疫苗接种和监测,以预防cVDPV暴发。
- 使用非脊灰AFP病例的疫苗接种状态作为覆盖率替代指标,可识别免疫缺口。
- 快速开展多轮mOPV2疫苗接种是控制cVDPV2暴发的有效手段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Outbreaks of circulating vaccine-derived polioviruses (cVDPVs) pose a threat to the eventual eradication of all polioviruses. In 2017, an outbreak of cVDPV type 2 (cVDPV2) occurred in the midst of a war in Syria. We describe vaccination-based risk factors for and the successful response to the outbreak. METHODS: We performed a descriptive analysis of cVDPV2 cases and key indicators of poliovirus surveillance and vaccination activities during 2016-2018. In the absence of reliable subnational coverage data, we used the caregiver-reported vaccination status of children with non-polio acute flaccid paralysis (AFP) as a proxy for vaccination coverage. We then estimated the relative odds of being unvaccinated against polio, comparing children in areas affected by the outbreak to children in other parts of Syria in order to establish the presence of poliovirus immunity gaps in outbreak affected areas. FINDINGS: A total of 74 cVDPV2 cases were reported, with paralysis onset ranging from 3 March to 21 September 2017. All but three cases were reported from Deir-ez-Zor governorate and 84% had received < 3 doses of oral poliovirus vaccine (OPV). After adjusting for age and sex, non-polio AFP case-patients aged 6-59 months in outbreak-affected areas had 2.5 (95% CI: 1.1-5.7) increased odds of being unvaccinated with OPV compared with non-polio AFP case-patients in the same age group in other parts of Syria. Three outbreak response rounds of monovalent OPV type 2 (mOPV2) vaccination were conducted, with governorate-level coverage mostly exceeding 80%. INTERPRETATION: Significant declines in both national and subnational polio vaccination coverage, precipitated by war and a humanitarian crisis, led to a cVDPV2 outbreak in Syria that was successfully contained following three rounds of mOPV2 vaccination.
引用
- Mbaeyi C, Moran T, Wadood Z, et al. Stopping a polio outbreak in the midst of war: Lessons from Syria. Vaccine. 2021. PMID: 34053791. doi:10.1016/j.vaccine.2021.05.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。